David Leslie Adams is Director of Cardlytics, Inc.. Currently has a direct ownership of 40,514 shares of CDLX, which is worth approximately $150,306. The most recent transaction as insider was on May 24, 2023, when has been sold 6,465 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.5K
0% 3M change
0% 12M change
Total Value Held $150,306

David Leslie Adams Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 24 2023
BUY
Exercise of conversion of derivative security
-
6,465 Added 13.76%
40,514 Common Stock
May 21 2022
BUY
Exercise of conversion of derivative security
-
1,701 Added 4.76%
34,049 Common Stock
Jun 02 2021
BUY
Exercise of conversion of derivative security
-
2,023 Added 5.89%
32,348 Common Stock
Nov 13 2020
SELL
Open market or private sale
$2,642,188 $111.25 p/Share
23,750 Reduced 43.92%
30,325 Common Stock
Nov 13 2020
BUY
Exercise of conversion of derivative security
$1,188,450 $50.04 p/Share
23,750 Added 30.52%
54,075 Common Stock
DLA

David Leslie Adams

Director
Atlanta, GA

Track Institutional and Insider Activities on CDLX

Follow Cardlytics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDLX shares.

Notify only if

Insider Trading

Get notified when an Cardlytics, Inc. insider buys or sells CDLX shares.

Notify only if

News

Receive news related to Cardlytics, Inc.

Track Activities on CDLX